Skip to main content

Table 2 Determination of CAR and IVA in their laboratory-prepared mixtures by the proposed methods

From: A unique revolutionary eco-friendly spectrophotometric technique for solving the spectral overlap in the determination of carvedilol and ivabradine in their binary combination: stability study

CAR and IVA in absence of their degradation products (set A)

CAR: IVA

Concentration (µg/ml)

Recovery%

CAR

IVA

CAR

IVA

RD

FDW-SS

CC-SS

RD

FDW-SS

CC-SS

1:2.5

6

15

101.67

101.84

98.65

100.20

98.10

100.92

1:3

8

24

101.00

101.20

98.19

100.75

98.14

101.00

1:1

10

10

101.00

99.58

98.41

101.60

98.60

101.77

2.5:1*

15

6

100.27

98.74

98.77

98.33

98.81

101.89

3:1

24

8

100.13

99.30

98.09

101.88

98.85

100.83

Mean ± SD

100.81 ± 0.63

100.13 ± 1.32

99.42 ± 0.29

100.55 ± 1.41

98.50 ± 0.36

101.28 ± 0.51

CAR and IVA in presence of their oxidative degradation products (set B)

% Degradation

CAR: IVA: CAR':IVA'

Recovery%

CAR':IVA'

CAR

IVA

ITAD-RS

ITAD-RS

10

6:15:5.4:13.5

99.80

98.80

30

8:24:5.6:16.8

98.44

101.46

50

10:10:5:5

99.34

101.20

70

15:6:4.5:1.8

98.09

99.67

90

24:8:2.4:0.8

98.27

100.13

Mean ± SD

98.78 ± 0.74

100.25 ± 1.00

  1. *Ratio found in pharmaceutical dosage form